Less invasive techniques and learning curve effects improve the outcome after extrapleural pneumonectomy for malignant pleural mesothelioma (Poster presentation,General Lecture) 2013/05
2.
Combination efficacy of m TOR and MEK inhibitor in malignant pleural mesothelioma(MPM) (Newspaper announcement,General Lecture) 2013/05/31
3.
Activation of mTOR signal pathway is associated with prolonged survival in malignant pleural mesothelioma patients (Poster presentation,General Lecture) 2013/10/28
4.
Association of activation of mTOR and MAPK signal pathway is associated with prolonged survival in parient with malignant pleural mesothelioma (Poster presentation,General Lecture) 2014/05/30
5.
Post-recurrence additional chemotherapy is feasible and effective in patients undergoing extrapleural pneumonectomy for malignant pleural mesothelioma (Poster presentation,General Lecture) 2014/09/29
6.
Diagnostic total parietal pleurectomy for pathologically-undetermined radiological/thoracoscopis TO malignant pleural mesothelioma. (Poster presentation,General Lecture) 2014/10/22
7.
Early results of consecutive 27 patients who underwent pleurectomy / decortication for malignant pleutral mesothelioma (Poster presentation,General Lecture) 2014/10/22
8.
The incidence and risk factors of part site seeding in MPM patients undergoing radical surgery (Poster presentation,General Lecture) 2014/10/22
9.
A case of spindle cell neoplasia in the pleura (Oral presentation,General Lecture) 2015/10/31
10.
Induction Chemotherapy Followed by Surgery for Malignant Pleural Mesothelioma (Poster presentation,General Lecture) 2016/05/03
11.
The Analysis of the Recurrence of the Patients Who Underwent Surgical Resection for Malignant Pleural Mesothelioma (Poster presentation,General Lecture) 2016/05/03